Antibodies to IL-6 and use thereof

Details for Australian Patent Application No. 2008254584 (hide)

Owner Alder Biopharmaceuticals, Inc.

Inventors Jensen, Anne Elisabeth Carvalho; Garcia-Martinez, Leon; Ojala, Ethan; Latham, John; Dutzar, Ben; Kovacevich, Brian; Olson, Katie; Smith, Jeffrey T.L.

Agent Watermark

Pub. Number AU-A-2008254584

PCT Pub. Number WO2008/144763

Priority 60/924,550 21.05.07 US

Filing date 21 May 2008

Wipo publication date 27 November 2008

International Classifications

A61K 39/395 (2006.01) Medicinal preparations containing antigens or antibodies - Antibodies

C07K 16/24 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

Event Publications

17 December 2009 PCT application entered the National Phase

  PCT publication WO2008/144763 Priority application(s): WO2008/144763

23 February 2012 Assignment before Grant

  Alder Biopharmaceuticals, Inc. The application has been assigned to Alder BioHoldings LLC

5 April 2012 Alteration of Name

  The name of the applicant has been altered to Alder BioHoldings LLC; Bristol-Myers Squibb Company

3 May 2012 Alteration of Name

  The name of the applicant has been altered to AlderBio Holdings LLC; Bristol-Myers Squibb Company

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008254585-Compositions, synthesis, and methods of using quinolinone based atypical antipsychotic agents

2008254582-Methods and compositions for identifying and treating lupus